| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ion channel regulator activity | 4.27e-05 | 162 | 115 | 7 | GO:0099106 | |
| GeneOntologyMolecularFunction | channel regulator activity | 6.72e-05 | 174 | 115 | 7 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 7.48e-05 | 177 | 115 | 7 | GO:0141108 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | A1CF ANK2 KSR2 NCK1 IFI16 SUV39H2 SH2B1 SNAP29 MAGI2 YEATS2 KMT2D BRD8 AKAP9 SYNE2 CDYL2 TACC1 RBM47 ENO1 WNK3 VCL | 8.85e-05 | 1356 | 115 | 20 | GO:0060090 |
| GeneOntologyMolecularFunction | RNA transmembrane transporter activity | 9.83e-05 | 3 | 115 | 2 | GO:0051033 | |
| GeneOntologyMolecularFunction | nucleic acid transmembrane transporter activity | 9.83e-05 | 3 | 115 | 2 | GO:0051032 | |
| GeneOntologyMolecularFunction | telomeric repeat-containing RNA binding | 9.83e-05 | 3 | 115 | 2 | GO:0061752 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | A1CF ANK2 KSR2 NCK1 IFI16 SUV39H2 SH2B1 SNAP29 MAGI2 YEATS2 KMT2D BRD8 SYNE2 CDYL2 TACC1 RBM47 ENO1 WNK3 | 1.11e-04 | 1160 | 115 | 18 | GO:0030674 |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 1.19e-04 | 44 | 115 | 4 | GO:0140938 | |
| GeneOntologyMolecularFunction | phosphopyruvate hydratase activity | 1.96e-04 | 4 | 115 | 2 | GO:0004634 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNAH3 ATP8B4 CENPE MYO7B ATP8B2 ATP10D DHX30 MSH6 DDX46 MDN1 ABCD2 DNAH9 | 2.21e-04 | 614 | 115 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | calcium channel regulator activity | 2.64e-04 | 54 | 115 | 4 | GO:0005246 | |
| GeneOntologyMolecularFunction | histone H3K9 trimethyltransferase activity | 3.25e-04 | 5 | 115 | 2 | GO:0140949 | |
| GeneOntologyMolecularFunction | RNA strand annealing activity | 3.25e-04 | 5 | 115 | 2 | GO:0033592 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 5.49e-04 | 28 | 115 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | magnesium ion binding | 5.74e-04 | 247 | 115 | 7 | GO:0000287 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 6.40e-04 | 68 | 115 | 4 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 6.76e-04 | 69 | 115 | 4 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 7.54e-04 | 71 | 115 | 4 | GO:0042054 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 9.00e-04 | 8 | 115 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.03e-03 | 441 | 115 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | histone H3K9me2 methyltransferase activity | 1.44e-03 | 10 | 115 | 2 | GO:0140947 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 1.44e-03 | 10 | 115 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | telomeric DNA binding | 1.57e-03 | 40 | 115 | 3 | GO:0042162 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DNAH3 ATP8B4 RRAD NKIRAS1 ATP8B2 ATP10D DHX30 DDX46 MDN1 ABCD2 REM2 DNAH9 | 1.71e-03 | 775 | 115 | 12 | GO:0017111 |
| GeneOntologyMolecularFunction | G-rich strand telomeric DNA binding | 1.75e-03 | 11 | 115 | 2 | GO:0098505 | |
| GeneOntologyMolecularFunction | DNA/DNA annealing activity | 1.75e-03 | 11 | 115 | 2 | GO:1990814 | |
| GeneOntologyMolecularFunction | protein phosphatase 2A binding | 1.81e-03 | 42 | 115 | 3 | GO:0051721 | |
| GeneOntologyMolecularFunction | histone H3K9 methyltransferase activity | 2.46e-03 | 13 | 115 | 2 | GO:0046974 | |
| GeneOntologyMolecularFunction | single-stranded telomeric DNA binding | 2.46e-03 | 13 | 115 | 2 | GO:0043047 | |
| GeneOntologyMolecularFunction | annealing activity | 2.86e-03 | 14 | 115 | 2 | GO:0140666 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 2.98e-03 | 103 | 115 | 4 | GO:0008276 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 3.17e-03 | 51 | 115 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 3.19e-03 | 105 | 115 | 4 | GO:0008170 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DNAH3 ATP8B4 RRAD NKIRAS1 ATP8B2 ATP10D DHX30 DDX46 MDN1 ABCD2 REM2 DNAH9 | 3.27e-03 | 839 | 115 | 12 | GO:0016462 |
| GeneOntologyMolecularFunction | sequence-specific single stranded DNA binding | 3.29e-03 | 15 | 115 | 2 | GO:0098847 | |
| GeneOntologyMolecularFunction | histone chaperone activity | 3.29e-03 | 15 | 115 | 2 | GO:0140713 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DNAH3 ATP8B4 RRAD NKIRAS1 ATP8B2 ATP10D DHX30 DDX46 MDN1 ABCD2 REM2 DNAH9 | 3.31e-03 | 840 | 115 | 12 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DNAH3 ATP8B4 RRAD NKIRAS1 ATP8B2 ATP10D DHX30 DDX46 MDN1 ABCD2 REM2 DNAH9 | 3.31e-03 | 840 | 115 | 12 | GO:0016818 |
| GeneOntologyMolecularFunction | cadherin binding | 3.50e-03 | 339 | 115 | 7 | GO:0045296 | |
| GeneOntologyMolecularFunction | signaling receptor complex adaptor activity | 3.73e-03 | 54 | 115 | 3 | GO:0030159 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 3.90e-03 | 111 | 115 | 4 | GO:0003727 | |
| GeneOntologyMolecularFunction | flippase activity | 4.23e-03 | 17 | 115 | 2 | GO:0140327 | |
| GeneOntologyMolecularFunction | phosphatase binding | 4.28e-03 | 264 | 115 | 6 | GO:0019902 | |
| GeneOntologyMolecularFunction | potassium channel regulator activity | 4.34e-03 | 57 | 115 | 3 | GO:0015459 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.74e-03 | 18 | 115 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.84e-03 | 118 | 115 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | sequence-specific mRNA binding | 5.27e-03 | 19 | 115 | 2 | GO:1990825 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 5.30e-03 | 276 | 115 | 6 | GO:0003730 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 5.56e-03 | 196 | 115 | 5 | GO:0005319 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 5.84e-03 | 20 | 115 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 5.84e-03 | 20 | 115 | 2 | GO:0008525 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 5.50e-05 | 14 | 114 | 3 | GO:1990531 | |
| GeneOntologyCellularComponent | phosphopyruvate hydratase complex | 1.76e-04 | 4 | 114 | 2 | GO:0000015 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 1.91e-04 | 97 | 114 | 5 | GO:0071013 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 2.70e-04 | 230 | 114 | 7 | GO:0019898 | |
| GeneOntologyCellularComponent | apolipoprotein B mRNA editing enzyme complex | 2.92e-04 | 5 | 114 | 2 | GO:0030895 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 3.33e-04 | 25 | 114 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | synaptic membrane | ANK2 ITPR1 MAGI2 AKAP9 OTOF ANP32E UNC13C GRIN3A CADPS2 ENO1 ENO2 | 3.47e-04 | 583 | 114 | 11 | GO:0097060 |
| GeneOntologyCellularComponent | cell-cell junction | 3.90e-04 | 591 | 114 | 11 | GO:0005911 | |
| GeneOntologyCellularComponent | nucleoplasmic periphery of the nuclear pore complex | 4.36e-04 | 6 | 114 | 2 | GO:1990826 | |
| GeneOntologyCellularComponent | sarcomere | 4.36e-04 | 249 | 114 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | intercalated disc | 5.22e-04 | 68 | 114 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | mRNA editing complex | 6.08e-04 | 7 | 114 | 2 | GO:0045293 | |
| GeneOntologyCellularComponent | myofibril | 7.52e-04 | 273 | 114 | 7 | GO:0030016 | |
| GeneOntologyCellularComponent | anchoring junction | EPPK1 NRAP ANK2 DSG2 NCK1 MFRP ADA MAGI2 CDH20 XIRP2 SYNE2 CDH4 WNK3 VCL | 8.63e-04 | 976 | 114 | 14 | GO:0070161 |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 9.31e-04 | 137 | 114 | 5 | GO:0019897 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.07e-03 | 290 | 114 | 7 | GO:0043292 | |
| GeneOntologyCellularComponent | spliceosomal complex | 1.17e-03 | 215 | 114 | 6 | GO:0005681 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | UTP6 A1CF SRSF1 SETD1B HNRNPA3 HNRNPA1L2 HNRNPA1 HNRNPA1L3 MSH6 KMT2D BRD8 DDX46 CLMN SUV39H1 SYNE2 ANP32E RBM47 | 1.27e-03 | 1377 | 114 | 17 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear outer membrane | 1.35e-03 | 40 | 114 | 3 | GO:0005640 | |
| GeneOntologyCellularComponent | Z disc | 1.44e-03 | 151 | 114 | 5 | GO:0030018 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 1.57e-03 | 11 | 114 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 1.57e-03 | 11 | 114 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 1.57e-03 | 11 | 114 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 1.57e-03 | 11 | 114 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.75e-03 | 94 | 114 | 4 | GO:0044291 | |
| GeneOntologyCellularComponent | I band | 2.18e-03 | 166 | 114 | 5 | GO:0031674 | |
| GeneOntologyCellularComponent | fascia adherens | 2.21e-03 | 13 | 114 | 2 | GO:0005916 | |
| GeneOntologyCellularComponent | Swr1 complex | 2.21e-03 | 13 | 114 | 2 | GO:0000812 | |
| GeneOntologyCellularComponent | heterochromatin | 2.28e-03 | 101 | 114 | 4 | GO:0000792 | |
| GeneOntologyCellularComponent | dynein complex | 3.20e-03 | 54 | 114 | 3 | GO:0030286 | |
| GeneOntologyCellularComponent | photoreceptor outer segment | 3.21e-03 | 111 | 114 | 4 | GO:0001750 | |
| GeneOntologyCellularComponent | cytoplasmic region | 3.61e-03 | 360 | 114 | 7 | GO:0099568 | |
| GeneOntologyCellularComponent | sarcolemma | 3.89e-03 | 190 | 114 | 5 | GO:0042383 | |
| Domain | Post-SET_dom | 1.96e-06 | 16 | 110 | 4 | IPR003616 | |
| Domain | PostSET | 1.96e-06 | 16 | 110 | 4 | SM00508 | |
| Domain | POST_SET | 1.96e-06 | 16 | 110 | 4 | PS50868 | |
| Domain | RRM_1 | A1CF SRSF1 SETD1B HNRNPA3 HNRNPA1L2 HNRNPA1 DAZAP1 RBM47 HNRNPLL | 3.90e-06 | 208 | 110 | 9 | PF00076 |
| Domain | RRM | A1CF SRSF1 SETD1B HNRNPA3 HNRNPA1L2 HNRNPA1 DAZAP1 RBM47 HNRNPLL | 5.50e-06 | 217 | 110 | 9 | SM00360 |
| Domain | RRM_dom | A1CF SRSF1 SETD1B HNRNPA3 HNRNPA1L2 HNRNPA1 DAZAP1 RBM47 HNRNPLL | 7.92e-06 | 227 | 110 | 9 | IPR000504 |
| Domain | RRM | A1CF SRSF1 SETD1B HNRNPA3 HNRNPA1L2 HNRNPA1 DAZAP1 RBM47 HNRNPLL | 8.80e-06 | 230 | 110 | 9 | PS50102 |
| Domain | - | A1CF SRSF1 SETD1B HNRNPA3 HNRNPA1L2 HNRNPA1 DAZAP1 RBM47 HNRNPLL | 1.41e-05 | 244 | 110 | 9 | 3.30.70.330 |
| Domain | Nucleotide-bd_a/b_plait | A1CF SRSF1 SETD1B HNRNPA3 HNRNPA1L2 HNRNPA1 DAZAP1 RBM47 HNRNPLL | 2.20e-05 | 258 | 110 | 9 | IPR012677 |
| Domain | Histone_H3-K9_MeTrfase | 3.44e-05 | 2 | 110 | 2 | IPR011381 | |
| Domain | SAM_MT43_SUVAR39_3 | 3.44e-05 | 2 | 110 | 2 | PS51579 | |
| Domain | P_typ_ATPase_c | 6.90e-05 | 14 | 110 | 3 | IPR032630 | |
| Domain | P-type_ATPase_N | 6.90e-05 | 14 | 110 | 3 | IPR032631 | |
| Domain | ATPase_dyneun-rel_AAA | 6.90e-05 | 14 | 110 | 3 | IPR011704 | |
| Domain | P-type_ATPase_IV | 6.90e-05 | 14 | 110 | 3 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 6.90e-05 | 14 | 110 | 3 | PF16212 | |
| Domain | PhoLip_ATPase_N | 6.90e-05 | 14 | 110 | 3 | PF16209 | |
| Domain | AAA_5 | 6.90e-05 | 14 | 110 | 3 | PF07728 | |
| Domain | SET | 9.75e-05 | 41 | 110 | 4 | PF00856 | |
| Domain | HnRNPA1 | 1.03e-04 | 3 | 110 | 2 | IPR021662 | |
| Domain | Enolase_N | 1.03e-04 | 3 | 110 | 2 | PF03952 | |
| Domain | Enolase | 1.03e-04 | 3 | 110 | 2 | IPR000941 | |
| Domain | Enolase_C | 1.03e-04 | 3 | 110 | 2 | IPR020810 | |
| Domain | Enolase_N | 1.03e-04 | 3 | 110 | 2 | IPR020811 | |
| Domain | Enolase_CS | 1.03e-04 | 3 | 110 | 2 | IPR020809 | |
| Domain | HnRNPA1 | 1.03e-04 | 3 | 110 | 2 | PF11627 | |
| Domain | Enolase_C | 1.03e-04 | 3 | 110 | 2 | PF00113 | |
| Domain | Enolase_N | 1.03e-04 | 3 | 110 | 2 | SM01193 | |
| Domain | Enolase_C | 1.03e-04 | 3 | 110 | 2 | SM01192 | |
| Domain | ENOLASE | 1.03e-04 | 3 | 110 | 2 | PS00164 | |
| Domain | Chromodomain_CS | 1.52e-04 | 18 | 110 | 3 | IPR023779 | |
| Domain | SET | 1.54e-04 | 46 | 110 | 4 | SM00317 | |
| Domain | - | 2.05e-04 | 4 | 110 | 2 | 3.30.390.10 | |
| Domain | Cortactin-binding_p2_N | 2.05e-04 | 4 | 110 | 2 | IPR019131 | |
| Domain | - | 2.05e-04 | 4 | 110 | 2 | 3.20.20.120 | |
| Domain | Enolase_C-like | 2.05e-04 | 4 | 110 | 2 | IPR029065 | |
| Domain | Enolase_N-like | 2.05e-04 | 4 | 110 | 2 | IPR029017 | |
| Domain | Small_GTPase_GEM/REM/Rad | 2.05e-04 | 4 | 110 | 2 | IPR017358 | |
| Domain | CortBP2 | 2.05e-04 | 4 | 110 | 2 | PF09727 | |
| Domain | SET_dom | 2.13e-04 | 50 | 110 | 4 | IPR001214 | |
| Domain | SET | 2.13e-04 | 50 | 110 | 4 | PS50280 | |
| Domain | HnRNP_R/Q_splicing_fac | 3.40e-04 | 5 | 110 | 2 | IPR006535 | |
| Domain | DUF1041 | 3.40e-04 | 5 | 110 | 2 | SM01145 | |
| Domain | Chromo_domain | 3.68e-04 | 24 | 110 | 3 | IPR023780 | |
| Domain | Cadherin_C | 4.16e-04 | 25 | 110 | 3 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 4.16e-04 | 25 | 110 | 3 | IPR000233 | |
| Domain | Cadherin_CS | 4.65e-04 | 109 | 110 | 5 | IPR020894 | |
| Domain | Chromo | 4.68e-04 | 26 | 110 | 3 | PF00385 | |
| Domain | CADHERIN_1 | 5.48e-04 | 113 | 110 | 5 | PS00232 | |
| Domain | Cadherin | 5.48e-04 | 113 | 110 | 5 | PF00028 | |
| Domain | - | 5.51e-04 | 64 | 110 | 4 | 3.40.50.1000 | |
| Domain | CADHERIN_2 | 5.70e-04 | 114 | 110 | 5 | PS50268 | |
| Domain | - | 5.70e-04 | 114 | 110 | 5 | 2.60.40.60 | |
| Domain | CHROMO_1 | 5.85e-04 | 28 | 110 | 3 | PS00598 | |
| Domain | CHROMO_2 | 5.85e-04 | 28 | 110 | 3 | PS50013 | |
| Domain | CA | 5.94e-04 | 115 | 110 | 5 | SM00112 | |
| Domain | Cadherin-like | 6.17e-04 | 116 | 110 | 5 | IPR015919 | |
| Domain | Catenin_binding_dom | 6.50e-04 | 29 | 110 | 3 | IPR027397 | |
| Domain | - | 6.50e-04 | 29 | 110 | 3 | 4.10.900.10 | |
| Domain | Cadherin | 6.67e-04 | 118 | 110 | 5 | IPR002126 | |
| Domain | Munc13_1 | 7.08e-04 | 7 | 110 | 2 | IPR014770 | |
| Domain | Pre-SET | 7.08e-04 | 7 | 110 | 2 | PF05033 | |
| Domain | MHD1 | 7.08e-04 | 7 | 110 | 2 | PS51258 | |
| Domain | PreSET | 7.08e-04 | 7 | 110 | 2 | SM00468 | |
| Domain | DUF1041 | 7.08e-04 | 7 | 110 | 2 | PF06292 | |
| Domain | CAPS_dom | 7.08e-04 | 7 | 110 | 2 | IPR010439 | |
| Domain | Pre-SET_dom | 7.08e-04 | 7 | 110 | 2 | IPR007728 | |
| Domain | PRE_SET | 7.08e-04 | 7 | 110 | 2 | PS50867 | |
| Domain | - | 8.71e-04 | 32 | 110 | 3 | 3.40.1110.10 | |
| Domain | - | 8.71e-04 | 32 | 110 | 3 | 2.70.150.10 | |
| Domain | Chromodomain-like | 8.71e-04 | 32 | 110 | 3 | IPR016197 | |
| Domain | S15_NS1_RNA-bd | 9.40e-04 | 8 | 110 | 2 | IPR009068 | |
| Domain | Chromo/shadow_dom | 9.54e-04 | 33 | 110 | 3 | IPR000953 | |
| Domain | CHROMO | 9.54e-04 | 33 | 110 | 3 | SM00298 | |
| Domain | ATPase_P-typ_cyto_domN | 1.13e-03 | 35 | 110 | 3 | IPR023299 | |
| Domain | HAD-like_dom | 1.22e-03 | 79 | 110 | 4 | IPR023214 | |
| Domain | ATPase_P-typ_P_site | 1.23e-03 | 36 | 110 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 1.23e-03 | 36 | 110 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.23e-03 | 36 | 110 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.33e-03 | 37 | 110 | 3 | IPR008250 | |
| Domain | Small_GTPase_Ras | 1.33e-03 | 37 | 110 | 3 | IPR020849 | |
| Domain | E1-E2_ATPase | 1.33e-03 | 37 | 110 | 3 | PF00122 | |
| Domain | P-loop_NTPase | DNAH3 CENPE MYO7B RRAD NKIRAS1 DHX30 MAGI2 MSH6 DDX46 MDN1 ABCD2 REM2 DNAH9 | 1.44e-03 | 848 | 110 | 13 | IPR027417 |
| Domain | Hydrolase_3 | 1.50e-03 | 10 | 110 | 2 | PF08282 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.99e-03 | 14 | 110 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.99e-03 | 14 | 110 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.99e-03 | 14 | 110 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.99e-03 | 14 | 110 | 2 | PF08393 | |
| Domain | MT | 2.99e-03 | 14 | 110 | 2 | PF12777 | |
| Domain | AAA_8 | 2.99e-03 | 14 | 110 | 2 | PF12780 | |
| Domain | DHC_fam | 3.43e-03 | 15 | 110 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 3.43e-03 | 15 | 110 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 3.43e-03 | 15 | 110 | 2 | IPR004273 | |
| Domain | - | DNAH3 MYO7B RRAD NKIRAS1 DHX30 MSH6 DDX46 MDN1 ABCD2 REM2 DNAH9 | 4.52e-03 | 746 | 110 | 11 | 3.40.50.300 |
| Pubmed | 3.71e-08 | 3 | 117 | 3 | 15390079 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | UTP6 EPRS1 ATP8B4 SRSF1 DSG2 MAT2B HNRNPA3 PSMD12 HNRNPA1 DHX30 MSH6 IPO9 MDN1 DAZAP1 GGCT EIF2B1 ANP32E ENO1 HNRNPLL VCL | 5.97e-08 | 1425 | 117 | 20 | 30948266 |
| Pubmed | A1CF SRSF1 SETD1B HNRNPA3 HNRNPA1L2 HNRNPA1 DHX30 DAZAP1 RBM47 HNRNPLL | 2.98e-07 | 347 | 117 | 10 | 16033648 | |
| Pubmed | ANK2 DSG2 MAT2B CPD ADA HNRNPA1 DHX30 ITPR1 AIFM2 MDN1 AKAP9 ARHGEF10 CLMN SLC20A1 SYNE2 ANP32E TACC1 MARK2 VCL | 5.56e-07 | 1487 | 117 | 19 | 33957083 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EPRS1 ANK2 DSG2 HNRNPA1 DHX30 SNAP29 YEATS2 MSH6 DDX46 CLMN ANP32E TACC1 ENO1 TASOR VCL | 6.03e-07 | 934 | 117 | 15 | 33916271 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | EPPK1 SRSF1 HNRNPA3 PSMD12 HNRNPA1 MSH6 BRD8 DDX46 IPO9 MDN1 MARK2 HNRNPLL | 6.70e-07 | 582 | 117 | 12 | 20467437 |
| Pubmed | Binding of DAZAP1 and hnRNPA1/A2 to an exonic splicing silencer in a natural BRCA1 exon 18 mutant. | 7.37e-07 | 6 | 117 | 3 | 18391021 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EPPK1 DSG2 HNRNPA3 PSMD12 FNBP1L HNRNPA1 CTTNBP2NL SNAP29 MSH6 DDX46 IPO9 GGCT SLC20A1 SYNE2 ANP32E ENO1 METAP2 VCL | 7.46e-07 | 1367 | 117 | 18 | 32687490 |
| Pubmed | 8.49e-07 | 22 | 117 | 4 | 12456657 | ||
| Pubmed | EPRS1 EPPK1 SRSF1 SETD1B HNRNPA3 PSMD12 FNBP1L HNRNPA1 KMT2D DDX46 PIP4K2A ENO1 METAP2 | 8.62e-07 | 711 | 117 | 13 | 33022573 | |
| Pubmed | 1.01e-06 | 497 | 117 | 11 | 23414517 | ||
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | SRSF1 HNRNPA1L2 PSMD12 IFI16 HNRNPA1 DHX30 EIF2B1 MARK2 ENO1 | 1.32e-06 | 316 | 117 | 9 | 31665637 |
| Pubmed | EPRS1 SRSF1 HNRNPA3 HNRNPA1 ATP10D DHX30 MSH6 DDX46 GGCT ANP32E CFAP57 ENO1 | 1.83e-06 | 641 | 117 | 12 | 36057605 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | UTP6 EPRS1 EPPK1 SRSF1 DSG2 HNRNPA3 HNRNPA1 DHX30 DDX46 MDN1 DAZAP1 SLC20A1 SYNE2 MARK2 ENO1 | 1.88e-06 | 1024 | 117 | 15 | 24711643 |
| Pubmed | 1.94e-06 | 109 | 117 | 6 | 29511296 | ||
| Pubmed | RNA association and nucleocytoplasmic shuttling by ataxin-1. | 2.05e-06 | 8 | 117 | 3 | 15615787 | |
| Pubmed | Unconventional molecular regulation of synaptic vesicle replenishment in cochlear inner hair cells. | 2.05e-06 | 8 | 117 | 3 | 25609709 | |
| Pubmed | EPRS1 DSG2 NCK1 SNAP29 YEATS2 MSH6 KMT2D BRD8 DDX46 ENO1 VCL | 2.64e-06 | 549 | 117 | 11 | 38280479 | |
| Pubmed | 2.77e-06 | 346 | 117 | 9 | 25324306 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UTP6 EPRS1 PDCD2 SRSF1 SETD1B HNRNPA3 IFI16 HNRNPA1 DHX30 MSH6 IPO9 MDN1 GGCT PIP4K2A ENO1 METAP2 VCL | 2.94e-06 | 1353 | 117 | 17 | 29467282 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 3.65e-06 | 358 | 117 | 9 | 32460013 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | EPRS1 EPPK1 SRSF1 DSG2 HNRNPA3 HNRNPA1L2 IFI16 HNRNPA1 DHX30 ITPR1 DDX46 EIF2B1 MARK2 ENO1 | 3.93e-06 | 949 | 117 | 14 | 36574265 |
| Pubmed | The RNA recognition motif protein RBM11 is a novel tissue-specific splicing regulator. | 4.38e-06 | 10 | 117 | 3 | 21984414 | |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 5.31e-06 | 375 | 117 | 9 | 32788342 | |
| Pubmed | RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway. | 6.00e-06 | 11 | 117 | 3 | 37142680 | |
| Pubmed | EPRS1 SRSF1 ANK2 HNRNPA3 SPIRE1 HNRNPA1L2 HNRNPA1 DHX30 PITPNM1 MAGI2 CLMN VCAN PIP4K2A MARK2 ENO2 METAP2 VCL | 6.17e-06 | 1431 | 117 | 17 | 37142655 | |
| Pubmed | A novel SR-related protein is required for the second step of Pre-mRNA splicing. | 7.98e-06 | 12 | 117 | 3 | 15798186 | |
| Pubmed | EPRS1 SPIRE1 ATP8B2 SNAP29 YEATS2 MSH6 BRD8 DDX46 ANP32E VCL | 8.64e-06 | 506 | 117 | 10 | 30890647 | |
| Pubmed | 8.73e-06 | 399 | 117 | 9 | 37536630 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | UTP6 EPRS1 SRSF1 HNRNPA3 PSMD12 HNRNPA1 DHX30 YEATS2 MSH6 DDX46 IPO9 MDN1 PIP4K2A ANP32E ENO1 METAP2 | 9.09e-06 | 1318 | 117 | 16 | 30463901 |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 14690610 | ||
| Pubmed | Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. | 1.12e-05 | 2 | 117 | 2 | 14690609 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 32960212 | ||
| Pubmed | Nucleotide sequences of cDNAs alpha and gamma enolase mRNAs from mouse brain. | 1.12e-05 | 2 | 117 | 2 | 2362815 | |
| Pubmed | siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference. | 1.12e-05 | 2 | 117 | 2 | 15215364 | |
| Pubmed | Phosphorylation of hnRNP A1-Serine 199 Is Not Required for T Cell Differentiation and Function. | 1.12e-05 | 2 | 117 | 2 | 38334757 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 22551201 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 30779465 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 1406633 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 10843177 | ||
| Pubmed | Complete structure of the human gene encoding neuron-specific enolase. | 1.12e-05 | 2 | 117 | 2 | 2045099 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 28220845 | ||
| Pubmed | IGF-IR signaling attenuates the age-related decline of diastolic cardiac function. | 1.12e-05 | 2 | 117 | 2 | 22589390 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 11825891 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 28833505 | ||
| Pubmed | Cholinergic augmentation of insulin release requires ankyrin-B. | 1.12e-05 | 2 | 117 | 2 | 20234002 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 14722080 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 28760199 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 14765126 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 28912364 | ||
| Pubmed | Isolation of murine neuron-specific and non-neuronal enolase cDNA clones. | 1.12e-05 | 2 | 117 | 2 | 3801001 | |
| Pubmed | hnRNP A1 dysfunction in oligodendrocytes contributes to the pathogenesis of multiple sclerosis. | 1.12e-05 | 2 | 117 | 2 | 36382566 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 27426629 | ||
| Pubmed | HUPO BPP pilot study: a proteomics analysis of the mouse brain of different developmental stages. | 1.12e-05 | 2 | 117 | 2 | 17922513 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 18303017 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 14702045 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 11701123 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 38719473 | ||
| Pubmed | Extreme disruption of heterochromatin is required for accelerated hematopoietic aging. | 1.12e-05 | 2 | 117 | 2 | 32305044 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 23451023 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 24981170 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 31169879 | ||
| Pubmed | Regulation of mouse hepatitis virus RNA synthesis by heterogeneous nuclear ribonucleoprotein A1. | 1.12e-05 | 2 | 117 | 2 | 11774503 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 11774505 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 8041722 | ||
| Pubmed | Passenger deletions generate therapeutic vulnerabilities in cancer. | 1.12e-05 | 2 | 117 | 2 | 22895339 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 12560094 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FILIP1 EPRS1 IFI16 CTTNBP2NL PITPNM1 YEATS2 MSH6 KMT2D BRD8 DDX46 MDN1 MARK2 | 1.23e-05 | 774 | 117 | 12 | 15302935 |
| Pubmed | 1.26e-05 | 317 | 117 | 8 | 30997501 | ||
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 1.38e-05 | 90 | 117 | 5 | 35654790 | |
| Pubmed | 1.47e-05 | 538 | 117 | 10 | 28524877 | ||
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.55e-05 | 235 | 117 | 7 | 30258100 | |
| Pubmed | 1.64e-05 | 15 | 117 | 3 | 35907431 | ||
| Pubmed | HEY1 functions are regulated by its phosphorylation at Ser-68. | 1.80e-05 | 95 | 117 | 5 | 27129302 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SMG1 EPPK1 SRSF1 C2orf15 HNRNPA3 HNRNPA1 DHX30 DDX46 DAZAP1 NBPF10 RBM47 HNRNPLL | 1.86e-05 | 807 | 117 | 12 | 22681889 |
| Pubmed | 1.98e-05 | 244 | 117 | 7 | 29884807 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EPRS1 EPPK1 SRSF1 MAT2B HNRNPA3 FNBP1L HNRNPA1 DHX30 MSH6 DDX46 DAZAP1 GGCT SYNE2 ANP32E ENO1 METAP2 | 2.17e-05 | 1415 | 117 | 16 | 28515276 |
| Pubmed | 2.66e-05 | 172 | 117 | 6 | 26336360 | ||
| Pubmed | SMG1 EPRS1 ANK2 PCDHGB5 HNRNPA3 CAGE1 HNRNPA1L2 FNBP1L HNRNPA1 ADAMTS12 MDN1 SYNE2 PIP4K2A CADPS2 ENO1 TASOR | 2.73e-05 | 1442 | 117 | 16 | 35575683 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | SRSF1 HNRNPA3 HNRNPA1L2 FNBP1L HNRNPA1 DHX30 DAZAP1 HNRNPLL WNK3 | 2.77e-05 | 462 | 117 | 9 | 31138677 |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 2.82e-05 | 258 | 117 | 7 | 37794589 | |
| Pubmed | EPRS1 ANK2 DSG2 NCK1 CPD PSMD12 HNRNPA1 SNAP29 MARK2 ENO1 VCL | 2.83e-05 | 708 | 117 | 11 | 39231216 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | EPRS1 DNAH3 HNRNPA3 HNRNPA1L2 PSMD12 HNRNPA1 MSH6 IPO9 MDN1 PIP4K2A ENO1 ENO2 | 2.98e-05 | 847 | 117 | 12 | 35235311 |
| Pubmed | 3.12e-05 | 469 | 117 | 9 | 37314180 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 3.18e-05 | 361 | 117 | 8 | 26167880 | |
| Pubmed | Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis. | 3.36e-05 | 3 | 117 | 2 | 23827524 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 25901972 | ||
| Pubmed | Ankyrin-B metabolic syndrome combines age-dependent adiposity with pancreatic β cell insufficiency. | 3.36e-05 | 3 | 117 | 2 | 26168218 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 21454539 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 21896933 | ||
| Pubmed | PRMT5 regulates IRES-dependent translation via methylation of hnRNP A1. | 3.36e-05 | 3 | 117 | 2 | 28115626 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 31682228 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 30309881 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 38320300 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 37525910 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 15788566 | ||
| Pubmed | HuR-regulated mRNAs associated with nuclear hnRNP A1-RNP complexes. | 3.36e-05 | 3 | 117 | 2 | 24152440 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 33692334 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 19129513 | ||
| Pubmed | H3K9me3-heterochromatin loss at protein-coding genes enables developmental lineage specification. | 3.36e-05 | 3 | 117 | 2 | 30606806 | |
| Interaction | OR9Q2 interactions | 1.80e-06 | 5 | 115 | 3 | int:OR9Q2 | |
| GeneFamily | RNA binding motif containing | A1CF SRSF1 SETD1B HNRNPA3 HNRNPA1L2 HNRNPA1 DAZAP1 RBM47 HNRNPLL | 9.43e-07 | 213 | 88 | 9 | 725 |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.17e-05 | 34 | 88 | 4 | 487 | |
| GeneFamily | ATPase phospholipid transporting | 4.86e-05 | 15 | 88 | 3 | 1210 | |
| GeneFamily | RGK type GTPase family | 1.40e-04 | 4 | 88 | 2 | 1260 | |
| GeneFamily | Neuroblastoma breakpoint family | 1.84e-04 | 23 | 88 | 3 | 662 | |
| GeneFamily | Dyneins, axonemal | 3.04e-03 | 17 | 88 | 2 | 536 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | UTP6 SMG1 EPRS1 SRSF1 DSG2 CENPE ZNF112 ADA HNRNPA1 SUV39H2 YEATS2 MSH6 IPO9 ARHGEF10 GGCT EIF2B1 VCAN ENO1 HNRNPLL | 1.48e-05 | 1407 | 117 | 19 | M14427 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CENPE NCK1 FNBP1L ITPR1 MSH6 IGF1R MDN1 AKAP9 ARHGEF10 SYNE2 PIP4K2A TASOR VCL MYBL1 | 2.88e-05 | 856 | 117 | 14 | M4500 |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | EPRS1 SRSF1 CAPN6 CAGE1 HNRNPA1L2 HNRNPA1 CTTNBP2NL BRD8 ANP32E MARK2 VCL | 3.27e-05 | 543 | 117 | 11 | MM997 |
| Coexpression | GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN | 3.31e-05 | 200 | 117 | 7 | M5560 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN | 3.31e-05 | 200 | 117 | 7 | M3188 | |
| Coexpression | SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP | 3.37e-05 | 82 | 117 | 5 | M9224 | |
| Coexpression | PROVENZANI_METASTASIS_UP | 3.76e-05 | 204 | 117 | 7 | M4100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.37e-05 | 271 | 112 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | CAPN6 NPAS3 ARHGEF25 IL1RL2 HNRNPA1 ATP10D ADAMTS12 MAGI2 YEATS2 CFAP54 CLMN VCAN PRKG1 ABCD2 WNK3 | 1.92e-05 | 797 | 112 | 15 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | ANK2 CENPE KSR2 FNBP1L ADA SUV39H2 DHX30 CFAP54 DDX46 AKAP9 SLC20A1 SYNE2 MYLK4 ANP32E CDH4 WNK3 MYBL1 | 3.97e-05 | 1060 | 112 | 17 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 5.90e-05 | 186 | 112 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 7.21e-05 | 192 | 112 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | CENPE CAPN6 FNBP1L ADA IL1RL2 SUV39H2 CTTNBP2NL DHX30 CFAP54 DDX46 MDN1 AKAP9 SLC20A1 VCAN SYNE2 MYLK4 WNK3 MYBL1 | 9.45e-05 | 1252 | 112 | 18 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ANK2 CENPE SPIRE1 FNBP1L ADA SUV39H2 DHX30 MSH6 AIFM2 DDX46 MDN1 AKAP9 GGCT SLC20A1 SYNE2 ANP32E WNK3 MYBL1 | 9.94e-05 | 1257 | 112 | 18 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | PPP1R21 EPRS1 CENPE HNRNPA3 NPAS3 CPD SNAP29 AIFM2 DDX46 AKAP9 SLC20A1 SYNE2 CDH4 MYBL1 | 1.21e-04 | 831 | 112 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | FILIP1 ANK2 CENPE KSR2 SIDT1 FNBP1L ADA SUV39H2 DHX30 CFAP54 DDX46 AKAP9 SLC20A1 SYNE2 MYLK4 ANP32E CDH4 WNK3 MYBL1 | 1.44e-04 | 1414 | 112 | 19 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | SRSF1 ANK2 CENPE CAPN6 NPAS3 SPIRE1 ADA SUV39H2 AIFM2 DDX46 MDN1 AKAP9 SYNE2 KATNIP CDH4 | 2.03e-04 | 983 | 112 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | FILIP1 NPAS3 CPD SUV39H2 ITPR1 AKAP9 VCAN GRIN3A FAM118A CADPS2 ENO2 VCL MYBL1 | 2.17e-04 | 772 | 112 | 13 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | DSG2 CENPE CAPN6 HNRNPA3 FNBP1L ADA CTTNBP2NL DHX30 AIFM2 DDX46 IPO9 AKAP9 SLC20A1 SYNE2 ENO1 | 2.17e-04 | 989 | 112 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 2.33e-04 | 232 | 112 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.46e-04 | 311 | 112 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | CENPE NPAS3 CTTNBP2NL DHX30 MSH6 AIFM2 DDX46 AKAP9 GGCT SLC20A1 | 2.79e-04 | 492 | 112 | 10 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500 | 2.98e-04 | 496 | 112 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | SMG1 DSG2 CENPE CPD RRAD DHX30 DDX46 AKAP9 SLC20A1 CADPS2 RBM47 REM2 CDH4 | 3.09e-04 | 801 | 112 | 13 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.41e-08 | 186 | 117 | 8 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.31e-08 | 197 | 117 | 8 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.31e-08 | 197 | 117 | 8 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-07 | 182 | 117 | 7 | 587636c0f127231de21acd8aa632b74ff22ca8c2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-07 | 182 | 117 | 7 | adfadd7893e74b3002f13f00875e3667d3493e0c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-07 | 185 | 117 | 7 | 03f64a7132b13a01ba47187e0e15c13ac88f7cb2 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.23e-07 | 186 | 117 | 7 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.46e-07 | 187 | 117 | 7 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.19e-07 | 190 | 117 | 7 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.19e-07 | 190 | 117 | 7 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 7.19e-07 | 190 | 117 | 7 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.26e-07 | 194 | 117 | 7 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.26e-07 | 194 | 117 | 7 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.26e-07 | 194 | 117 | 7 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.26e-07 | 194 | 117 | 7 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.55e-07 | 195 | 117 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.55e-07 | 195 | 117 | 7 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.16e-07 | 197 | 117 | 7 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.16e-07 | 197 | 117 | 7 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.16e-07 | 197 | 117 | 7 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.47e-07 | 198 | 117 | 7 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.01e-06 | 200 | 117 | 7 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-06 | 166 | 117 | 6 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.50e-06 | 168 | 117 | 6 | 50991eb794742592a0c96cd9a72460ab339e74ff | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.95e-06 | 175 | 117 | 6 | c01a15b2084da4a18f8ff3623f44eb9dfe499f10 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.42e-06 | 177 | 117 | 6 | 844017225e9039d1bc621a9630a30c2e9a51b36d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.66e-06 | 178 | 117 | 6 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.17e-06 | 180 | 117 | 6 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.26e-06 | 184 | 117 | 6 | 9e5f98f9113e5e38bdadba6d9d2c346177fb35fe | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-06 | 184 | 117 | 6 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.26e-06 | 184 | 117 | 6 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-06 | 184 | 117 | 6 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-06 | 184 | 117 | 6 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.55e-06 | 185 | 117 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.55e-06 | 185 | 117 | 6 | 5a0340c25196453f19e424d346efbf66d2c53ac3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.84e-06 | 186 | 117 | 6 | d65fa6d8e8a195ea10cfde1499d096d6acf7a634 | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 9.84e-06 | 186 | 117 | 6 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.01e-05 | 187 | 117 | 6 | bc1f33f332ac939c2425f510173430ca2ba0c3ee | |
| ToppCell | Multiciliated|World / shred by cell class for nasal brushing | 1.08e-05 | 189 | 117 | 6 | 34b110aef839376228c5a403a6b5047a945f472b | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.11e-05 | 190 | 117 | 6 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.18e-05 | 192 | 117 | 6 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | COVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type | 1.18e-05 | 192 | 117 | 6 | d32ae226d95b4b6adb99d14b602be09b661d4cd9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-05 | 193 | 117 | 6 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.21e-05 | 193 | 117 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.21e-05 | 193 | 117 | 6 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.21e-05 | 193 | 117 | 6 | b9769b45125d2244afe53f9f71c92c04ddccf980 | |
| ToppCell | Control-Lymphoid-pDC|Lymphoid / Condition, Lineage and Cell class | 1.25e-05 | 194 | 117 | 6 | 5f95a5a35f73222dbe2ca52cc580f4774f641403 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.29e-05 | 195 | 117 | 6 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.29e-05 | 195 | 117 | 6 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.29e-05 | 195 | 117 | 6 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-05 | 196 | 117 | 6 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.33e-05 | 196 | 117 | 6 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.33e-05 | 196 | 117 | 6 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.33e-05 | 196 | 117 | 6 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 196 | 117 | 6 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 196 | 117 | 6 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.33e-05 | 196 | 117 | 6 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.36e-05 | 197 | 117 | 6 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.36e-05 | 197 | 117 | 6 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-05 | 197 | 117 | 6 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-05 | 197 | 117 | 6 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | T_cells-CTLs|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.36e-05 | 197 | 117 | 6 | 28117cf300e169182571fbad0de1681a484a435a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-05 | 197 | 117 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-05 | 197 | 117 | 6 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-05 | 197 | 117 | 6 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 198 | 117 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.40e-05 | 198 | 117 | 6 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.44e-05 | 199 | 117 | 6 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.44e-05 | 199 | 117 | 6 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.49e-05 | 200 | 117 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-05 | 200 | 117 | 6 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Neuronal-Neurons|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.49e-05 | 200 | 117 | 6 | b9538eb33ac86384e7e289a5a82fac4d56a7b9c2 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-05 | 200 | 117 | 6 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.49e-05 | 200 | 117 | 6 | 6a34e07e6d77fe3fdd9ff44c4b1e46a023f6d6a2 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-05 | 200 | 117 | 6 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.49e-05 | 200 | 117 | 6 | 721371698bce8890853fb6b6b01a2c20293b39e9 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-05 | 200 | 117 | 6 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.49e-05 | 200 | 117 | 6 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-05 | 200 | 117 | 6 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-05 | 200 | 117 | 6 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-05 | 200 | 117 | 6 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.49e-05 | 200 | 117 | 6 | 13ec8afea86e4a10599c924871ba4e325b0a8013 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Necab1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.07e-05 | 126 | 117 | 5 | a4fc7ac4931d2fc8aa8196a62d809b698937aa9c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Mme_Fam114a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.69e-05 | 133 | 117 | 5 | fc319644868078ea0f88a71d55f5e858c6848b50 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.20e-05 | 146 | 117 | 5 | 7b863f9bc63dc1afe015a18a70cd6ed0b71d1f09 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 4.48e-05 | 148 | 117 | 5 | a1269312903fc27830c1835dabf660c659a711be | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 6.30e-05 | 159 | 117 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 159 | 117 | 5 | 00a157d033627d0e65c3fbd38d652c4cf56b47f6 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 6.49e-05 | 160 | 117 | 5 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.49e-05 | 160 | 117 | 5 | dd16ca90feb3ae88b6409d6c278b4765da565514 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 6.69e-05 | 161 | 117 | 5 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 6.89e-05 | 162 | 117 | 5 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-05 | 165 | 117 | 5 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-05 | 165 | 117 | 5 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.41e-05 | 169 | 117 | 5 | 632aa3ab39ec87bafcefec6cddf71129a054d3b0 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.65e-05 | 170 | 117 | 5 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.65e-05 | 170 | 117 | 5 | 8ab67e2b6e30fdf9e9a2c02e31d4df34e751a3ed | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.13e-05 | 172 | 117 | 5 | 92e76cbf4807704790f42cf2507e92f85cd3bc92 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4-5_RORB_ASCL1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.39e-05 | 173 | 117 | 5 | 2e35bf2b5534a289d93a09faae660f665c131062 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.39e-05 | 173 | 117 | 5 | ee972d9cc68755926512fd3bbe1267098c67cd94 | |
| Disease | Malignant neoplasm of breast | SRSF1 ANK2 KBTBD8 RRAD SUV39H2 OR1N1 MSH6 KMT2D IGF1R CDH20 AKAP9 DAZAP1 OTOF SYNE2 ENO1 DNAH9 | 4.33e-06 | 1074 | 115 | 16 | C0006142 |
| Disease | Schizophrenia | SRSF1 HNRNPA3 NPAS3 SNAP29 PITPNM1 ADAMTS12 MAGI2 DAZAP1 PIP4K2A GRIN3A MARK2 CADPS2 ENO2 WNK3 | 9.03e-06 | 883 | 115 | 14 | C0036341 |
| Disease | myopathy (implicated_via_orthology) | 3.73e-05 | 48 | 115 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | glycosyl ceramide (d16:1/24:1, d18:1/22:1) measurement | 4.51e-05 | 3 | 115 | 2 | EFO_0800530 | |
| Disease | autosomal dominant limb-girdle muscular dystrophy type 3 (implicated_via_orthology) | 2.24e-04 | 6 | 115 | 2 | DOID:0110306 (implicated_via_orthology) | |
| Disease | Squamous cell carcinoma of lung | 2.63e-04 | 32 | 115 | 3 | C0149782 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.66e-04 | 145 | 115 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | glycosyl ceramide (d18:1/20:0, d16:1/22:0) measurement | 3.12e-04 | 7 | 115 | 2 | EFO_0800551 | |
| Disease | physical activity | 3.97e-04 | 88 | 115 | 4 | EFO_0003940 | |
| Disease | Neurodevelopmental Disorders | 4.89e-04 | 93 | 115 | 4 | C1535926 | |
| Disease | Bipolar Disorder | 5.75e-04 | 477 | 115 | 8 | C0005586 | |
| Disease | Adenoid Cystic Carcinoma | 6.44e-04 | 100 | 115 | 4 | C0010606 | |
| Disease | Chlamydia trachomatis seropositivity | 6.64e-04 | 10 | 115 | 2 | EFO_0009330 | |
| Disease | prostate carcinoma | ANK2 SIDT1 ZNF112 YEATS2 IGF1R SLC20A1 SYNE2 CDYL2 TACC1 FAM118A WNK3 | 7.34e-04 | 891 | 115 | 11 | EFO_0001663 |
| Disease | Microphthalmos | 8.09e-04 | 11 | 115 | 2 | C0026010 | |
| Disease | Enzymopathy | 8.09e-04 | 11 | 115 | 2 | C0520572 | |
| Disease | Pancreatic Ductal Adenocarcinoma | 8.09e-04 | 11 | 115 | 2 | C1335302 | |
| Disease | intracranial aneurysm (is_implicated_in) | 9.69e-04 | 12 | 115 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | interleukin-6 measurement | 9.84e-04 | 112 | 115 | 4 | EFO_0004810 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.30e-03 | 206 | 115 | 5 | C0152013 | |
| Disease | clonal hematopoiesis mutation measurement | 1.31e-03 | 55 | 115 | 3 | EFO_0020949 | |
| Disease | fourth ventricle volume measurement | 1.74e-03 | 16 | 115 | 2 | EFO_0010303 | |
| Disease | Romano-Ward Syndrome | 1.74e-03 | 16 | 115 | 2 | C0035828 | |
| Disease | breast carcinoma (is_marker_for) | 2.21e-03 | 66 | 115 | 3 | DOID:3459 (is_marker_for) | |
| Disease | thrombin activatable fibrinolysis inhibitor activation peptide measurement | 2.47e-03 | 19 | 115 | 2 | EFO_0008582 | |
| Disease | attention function measurement | 2.73e-03 | 148 | 115 | 4 | EFO_0007636 | |
| Disease | bipolar disorder, body mass index | 2.83e-03 | 72 | 115 | 3 | EFO_0004340, MONDO_0004985 | |
| Disease | nucleotide measurement | 2.94e-03 | 73 | 115 | 3 | EFO_0010513 | |
| Disease | Infiltrating duct carcinoma of female breast | 3.01e-03 | 21 | 115 | 2 | C3165106 | |
| Disease | behavioural disinhibition measurement | 3.18e-03 | 75 | 115 | 3 | EFO_0006946 | |
| Disease | Lewy Body Disease | 3.31e-03 | 22 | 115 | 2 | C0752347 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IVAEYEKTIAQMIED | 641 | O75410 | |
| VVYVKESDGLEMTDV | 76 | Q8WU43 | |
| TAEGDDVTYMLEKER | 126 | Q9P2B4 | |
| KTFVAETLEMGEVVE | 921 | Q99996 | |
| FVEMKAKEGVVYVEV | 86 | P00813 | |
| DMIETVYNDRGEIVK | 646 | O15013 | |
| CYKMEDIDIVVVAEV | 656 | Q96N23 | |
| EDMEGKYSVAEVFIT | 551 | Q96JP9 | |
| SELVETEKMYVDDLG | 166 | Q86VW2 | |
| TEKMYVDDLGQIVEG | 171 | Q86VW2 | |
| GEIPEMSVSYEKEVT | 241 | Q8TC20 | |
| MSVSYEKEVTAEGVE | 246 | Q8TC20 | |
| VYEDILGMQTDIDTE | 2586 | P13611 | |
| EVDEDTMSSVKILYV | 221 | Q9NQ94 | |
| DAIERIMSSYKEVTE | 401 | Q9UBJ2 | |
| LAEKMDIAVSYTGEE | 396 | Q9H0E9 | |
| ELTEELTKVMVDYIG | 386 | Q8IXS2 | |
| VGLSYLMKEEIQDEE | 216 | Q9BTT0 | |
| LVITMTAVKDATDDY | 86 | Q8TF62 | |
| NEYSEEEELVKGVLM | 1006 | Q7L2E3 | |
| FGVVTEVVMIYDAEK | 136 | Q96EP5 | |
| YTEKIVIGMDVAASE | 236 | P09104 | |
| VVVYTKGADSVIMEL | 791 | Q9P241 | |
| LVVADTKMIEYHGSE | 251 | P58397 | |
| YIETAELDGETNMKV | 181 | P98198 | |
| EQYGKIEVIEIMTDR | 126 | Q32P51 | |
| EQYGKIEVIEIMTDR | 81 | A0A2R8Y4L2 | |
| DVDEDVMETVKILYV | 236 | A0AV96 | |
| LVEMGDEYAVERAVT | 376 | Q8WVV9 | |
| IVVDGEEASLMVYDI | 131 | P55042 | |
| RYVSSEGTEKEEIMV | 3906 | Q01484 | |
| EGIVTLIKEVDYEEM | 331 | Q14126 | |
| MITQEEVVEVLSGYK | 491 | Q9BY79 | |
| GFDEMEVEIQTVKTE | 5221 | Q9NU22 | |
| GEAIQEVMESYEVEI | 301 | P50579 | |
| EVMESYEVEIDGKTY | 306 | P50579 | |
| EATRMEEGEVYAIET | 351 | P50579 | |
| YGEVEKLEESAVTVM | 186 | Q9NZL9 | |
| KMETGDVIVYINEVC | 466 | Q86UL8 | |
| MAEEVVVVAKFDYVA | 1 | P16333 | |
| MVEARKSLGEEYTED | 146 | Q86VF7 | |
| DSILEKYVTEIVMSI | 1481 | Q14643 | |
| DEIKDAIYVTMEILS | 471 | O60303 | |
| IKEGDVGSLVYVMED | 131 | Q13976 | |
| VGSLVYVMEDGKVEV | 136 | Q13976 | |
| YVMEDGKVEVTKEGV | 141 | Q13976 | |
| VGFAEEVLVTKTDME | 681 | Q96MR6 | |
| DVYMASVETDRGVKE | 41 | Q9NYS0 | |
| EMTDEQVCETVEKYG | 121 | Q6VAB6 | |
| VSEIYRMEEVTGTKG | 456 | P08069 | |
| TVVLDAAVGYIMEKA | 176 | Q14232 | |
| VVEKEDYSEIIGSMG | 206 | Q16342 | |
| ESKNDIVLVMEYVDG | 171 | Q86YV6 | |
| EQEGVKSGMYVVIEV | 96 | O75223 | |
| KAIYMDDDVIVQGDI | 166 | Q68CQ7 | |
| GRIVKMEVDYSATVD | 11 | O00232 | |
| DTLRMVTEGKIYVEI | 126 | O00232 | |
| EETKEYSMVVEGRDG | 306 | Q9Y5G0 | |
| AVVDGLTRKYMETIE | 156 | Q6ZMI0 | |
| EEMEVGTTYVTDKSE | 206 | P52701 | |
| TMYDEGQLTDIVVEV | 41 | Q8NFY9 | |
| AVMVGEKIYEELSGI | 766 | Q8TCU5 | |
| IELEKIEDYTVMPES | 486 | Q9HB29 | |
| YTDKVVIGMDVAASE | 236 | P06733 | |
| GYKDVTQDAEVMEVL | 206 | Q9NWS6 | |
| TLAMKEGEVLYIIEE | 556 | Q5T0N5 | |
| YDEITDLKQLTVVME | 2376 | Q8TD57 | |
| LDEGINAEMKYTIVD | 301 | Q9HBT6 | |
| KSVESRELYVMEISD | 531 | O75976 | |
| AEMEYQSGVTAVVEK | 291 | Q5T5S1 | |
| EGMVTVVKAVDYELN | 451 | P55283 | |
| VYCTMEVEGEKLQTD | 386 | Q86UW7 | |
| TTIYEIQDDRGKMDV | 331 | Q16666 | |
| FEVIETEKTLYLVME | 116 | Q7KZI7 | |
| IRVKGEEIYSMDEGI | 881 | Q96P70 | |
| EVMSKVYAVALIDSE | 251 | A6NC97 | |
| VRHEMTEGVTAYEEK | 1691 | Q9NYC9 | |
| YVEVPELAKMSQEEV | 336 | Q7L014 | |
| TVDMQKGRYTELVEE | 196 | Q9Y6Q1 | |
| EEGERLTKEVMSSYI | 301 | A6NK97 | |
| VSETIRKGLIDVEMY | 81 | Q8WUM9 | |
| DLTEEVVYTSEMALK | 166 | Q02224 | |
| ETVVYGKTEDQLIMT | 716 | P10243 | |
| RYIIKTITSEDVAEM | 141 | P48426 | |
| IIVIEIYDQDSMGKA | 1031 | Q9HC10 | |
| EEKDIAAAAMYTIVT | 266 | Q8NGS0 | |
| EMARYLVSTKEVGEE | 831 | O60469 | |
| AVYEEAVKTLPTEAM | 311 | Q9NYH9 | |
| VKVEGPSEYIMETVD | 346 | Q9NRF2 | |
| VITKSEMIEYHDISG | 1031 | P07814 | |
| KEYGFTEEEEIIMEA | 2001 | Q8WXH0 | |
| LEVVEGDLMKTEDEY | 646 | Q7Z7B0 | |
| EMAAEIKTEYPEKEV | 156 | Q9BRQ8 | |
| VGLAVDMDEIEKYQE | 2376 | Q6P3W6 | |
| GLAVDMDEIEKYQEV | 2621 | Q6P3W6 | |
| VGLAVDMDEIEKYQE | 3596 | Q6P3W6 | |
| VGLAVDMDEIEKYQE | 641 | A0A087WUL8 | |
| GLAIDMDEIEKYQEV | 886 | A0A087WUL8 | |
| VGLAVDMDEIEKYQE | 1861 | A0A087WUL8 | |
| GLAVDMDEIEKYQEV | 2106 | A0A087WUL8 | |
| VGLAVDMDEIEKYQE | 3081 | A0A087WUL8 | |
| GLAVDMDEIEKYQEV | 3326 | A0A087WUL8 | |
| VGLAVDMDEIEKYQE | 541 | P0DPF2 | |
| GLAVDMDEIEKYQEV | 786 | P0DPF2 | |
| VGLAVDMDEIEKYQE | 1761 | P0DPF2 | |
| GLAVDMDEIEKYQEV | 2006 | P0DPF2 | |
| VGLAVDMDEIEKYQE | 2981 | P0DPF2 | |
| GLAVDMDEIEKYQEV | 3226 | P0DPF2 | |
| VGLAVDMDEIEKYQE | 4201 | P0DPF2 | |
| MSVAEQVDYVIKEAT | 3631 | Q96Q15 | |
| EVTEMDSVKRYLEGT | 3276 | P58107 | |
| QEVTEMDSVKRYLEG | 4876 | P58107 | |
| LMYESEKVGVASSEE | 66 | O95721 | |
| DEVTEEYMELAKSRG | 1626 | Q9UPS6 | |
| GAMQIKVERYVESES | 551 | Q8IXF0 | |
| MEYVGEIITSEEAER | 271 | O43463 | |
| LYEVVEKTRIGSNME | 431 | Q9UK61 | |
| MASGDLYEVERIVDK | 1 | Q8N8U2 | |
| KVNLMTVEALEEGDY | 541 | Q96JQ2 | |
| GYSENIEMVTGIKEE | 346 | O43298 | |
| TEEVIQGDVKSYRML | 1126 | A4UGR9 | |
| IIEADEIGDVRMAKY | 1396 | A4UGR9 | |
| VVTLTGEKVDVYIMT | 946 | O00562 | |
| TDYVEVMEQVLAKLE | 876 | Q8NB66 | |
| ITLMVTIIDEDKTAY | 1596 | Q8NB66 | |
| METEVIESLGIIIYK | 121 | Q08AE8 | |
| DVDSVIIKVVSEMAY | 196 | Q9NXL6 | |
| FVMEYVGEVITSEEA | 276 | Q9H5I1 | |
| TVAEVVETMEDLVTY | 146 | P18206 | |
| IMVDKEEVTLVVYDI | 156 | Q8IYK8 | |
| FEKYGKIETIEVMED | 146 | P51991 | |
| EEMLSSKGLTVVDVY | 21 | Q86XW9 | |
| EMVTFKDVAVVFTEE | 6 | Q9UJU3 | |
| GTGVVEFVRKEDMTY | 156 | Q07955 | |
| VYETIISIDDKGQAM | 1336 | Q9C0G0 | |
| EQYGKIEVIEIMTDR | 126 | P09651 | |
| VYASVVEDMILKATE | 1351 | Q9ULM3 | |
| TDTPEEVAYEMVKSG | 456 | Q9BYP7 | |
| DLEKHTMVIEYIGTI | 5416 | O14686 | |
| TLKAEVIDVSYGMAD | 271 | Q58DX5 | |
| YDTVTDTEMVEKVFG | 906 | Q6PIF6 |